Bill
A 4163
Allows certain firearm licensees to open carry
2025 Regular Session
Introduced by Ken Blankenbush and 2 co-sponsors
NJ health insurers must cover biomarker precision testing when clinically indicated for diagnosis or disease management, per FDA/CMS guidance and comparable cost sharing.
REFERRED TO CODES